CLASS II Device recall · Reported 31 Mar 2021 · FDA Enforcement Report

The ImmunoCard Mycoplasma EIA detects the presence of IgM to M recalled

Meridian Bioscience is recalling The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in serum, distributed nationwide in the US. The recall was initiated on 8 Feb 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalog Number: 709030, Lot Number: 709030M114, Device Identifier: 00840733101762.
Quantity recalled8 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1299-2021
FDA event ID
87430
Recalling firm
Meridian Bioscience, Cincinnati, OH
Classification
Class II
Status
Terminated
Recall initiated
8 Feb 2021
FDA classified
24 Mar 2021
Reported
31 Mar 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

8 Feb 2021Recall initiated by company
24 Mar 2021Classified by FDA+44 days
31 Mar 2021Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Use of the kits after incorrect storage could lead to a potential false-negative or invalid result. In the event of a false-negative, the incorrect assumption would be made as to the cause of patient symptoms. The appropriate treatment may not be administered, and symptoms may progress. Additional evaluations will be completed and documented within the associated Health Hazard Evaluation.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in serum - Product Usage: intended to aid in the diagnosis of recent Mycoplasma pneumoniae infection.

Where it was distributed

US Nationwide distribution in the states of OH, SC.

Nationwide South Carolina

Questions about this recall

Why was it recalled?

Use of the kits after incorrect storage could lead to a potential false-negative or invalid result. In the event of a false-negative, the incorrect assumption would be made as to the cause of patient symptoms. The appropriate treatment may not be administered, and symptoms may progress. Additional evaluations will be completed and documented within the associated Health Hazard Evaluation.

Which lots are affected?

Catalog Number: 709030, Lot Number: 709030M114, Device Identifier: 00840733101762.

Where was it sold?

US Nationwide distribution in the states of OH, SC.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Meridian Bioscience

All 15

Other Other Medical Devices recalls

All 13,908